PubMed · 2543542
Immunity to rotaviruses.
Abstract
A potent, multivalent, serotype-specific RV vaccine and improved tests for measuring vaccine potency would help eliminate the necessity to pretest for vaccine efficacy in every country selected for its deployment. Until then, the need will continue for vaccine trials in various countries because the pathogenesis and epidemiology of RV and RV serotypes differ between and within countries. Although RV vaccinology is complex, it has forged ahead of our knowledge of RV immunopathogenesis and epidemiology.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
R Edelman, J Flores, A Z Kapikian. 1989. Immunity to rotaviruses.. https://doi.org/10.1007/978-3-642-74529-4_14
Cite the original work for its findings. Save a collection to share your selection of sources.